Companies get U.S. FDA warning letters over diabetes medicines

07/23/2013 | Reuters

The U.S. FDA has warned 15 domestic and international companies to stop selling 20 drugs that it says make false diabetes claims. Some of the drugs are said to be natural products while containing active pharmaceutical ingredients. Others are prescription drugs sold without a prescription, and still others falsely claim to alleviate symptoms, the agency said. FDA compliance officer Howard Sklamberg said that health care fraud with diabetes treatments is a particularly large problem.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI